Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery

BACKGROUND: Closed-loop insulin delivery is an emerging treatment for type 1 diabetes (T1D) evaluated clinically and using computer simulations during pre-clinical testing. Efforts to make closed-loop systems available to people with type 2 diabetes (T2D) calls for the development of a new type of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Yue, Thabit, Hood, Wilinska, Malgorzata E, Hovorka, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359432/
https://www.ncbi.nlm.nih.gov/pubmed/25889091
http://dx.doi.org/10.1186/s12938-015-0009-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359432/
https://www.ncbi.nlm.nih.gov/pubmed/25889091
http://dx.doi.org/10.1186/s12938-015-0009-5

Ejemplares similares